Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anastomotic Leak × Metronidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7 Surgical Wound Infection 4 Rectal Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 4 Pancreatic Neoplasms 3 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1 Postoperative Complications 1 Pilonidal Sinus 1 Mouth Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Inflammatory Bowel Diseases 1 Head and Neck Neoplasms 1 Familial primary gastric lymphoma 1 Diverticulitis 1 Colonic Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

Indocyanine Green 2 Ileostomy 2 Water 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Robotic Surgical Procedures 1 Neomycin 1 Metronidazole 1 Methods 1 Levofloxacin 1 Inulin 1 Fibrin Tissue Adhesive 1 Esophagectomy 1 Enoxaparin 1 Endoscopy 1 Enbucrilate 1 Congresses as Topic 1 Colistin 1 Ciprofloxacin 1 Cathartics 1 Bioseal 1 Amphotericin B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡